Actemra Side Effects
Generic name: tocilizumab
Note: This document contains side effect information about tocilizumab. Some of the dosage forms listed on this page may not apply to the brand name Actemra.
Some side effects of Actemra may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to tocilizumab: intravenous solution
Get emergency medical help if you have any of these signs of an allergic reaction while taking tocilizumab (the active ingredient contained in Actemra) hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Serious and sometimes fatal infections may occur during treatment with tocilizumab. Call your doctor right away if you have signs of infection such as:
-
fever, flu symptoms, mouth and throat ulcers, weight loss, feeling very tired;
-
sores in your mouth and throat or on your skin;
-
easy bruising, unusual bleeding (nose, mouth, vagina, or rectum);
-
purple or red pinpoint spots under your skin;
-
cough with yellow or green mucus, stabbing chest pain, feeling short of breath;
-
pain or burning when you urinate.
Call your doctor at once if you have any of these other serious side effects:
-
severe stomach pain with constipation;
-
bloody or tarry stools, coughing up blood or vomit that looks like coffee grounds;
-
painful blistering skin rash with burning, itching, or tingly feeling; or
-
upper stomach pain, vomiting, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).
Less serious side effects of tocilizumab may include:
-
runny or stuffy nose, sinus pain, sore throat;
-
headache, dizziness;
-
itching; or
-
mild stomach cramps.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to tocilizumab: intravenous solution
Respiratory
Respiratory side effects including upper respiratory tract infection (up to 8%), nasopharyngitis (up to 7%), and bronchitis (up to 4%) have been reported.
Nervous system
Nervous system side effects including headache (up to 7%) and dizziness (up to 3%) have been reported.
Cardiovascular
Cardiovascular side effects including hypertension (up to 6%) have been reported.
Hepatic
Hepatic side effects including increased ALT (up to 6%) and increased transaminase levels (up to 2%) have been reported.
Dermatologic
Dermatologic side effects including rash (up to 4%) have been reported.
General
General side effects including upper abdominal pain (up to 3%) has been reported.
Gastrointestinal
Gastrointestinal side effects including mouth ulceration (up to 2%), gastritis (up to 2%), and gastrointestinal perforation have been reported.
Hypersensitivity
Hypersensitivity side effects including clinically significant hypersensitivity reactions (e.g., anaphylactoid and anaphylactic reactions) (up to 0.2%) associated with tocilizumab (the active ingredient contained in Actemra) and requiring treatment discontinuation have been reported. Postmarketing reports of hypersensitivity reaction and anaphylaxis including events with a fatal outcome have been reported.
Oncologic
Oncologic side effects including malignancies have been reported.
More Actemra resources
- Actemra Prescribing Information (FDA)
- Actemra Monograph (AHFS DI)
- Actemra Advanced Consumer (Micromedex) - Includes Dosage Information
- Actemra Consumer Overview
- Actemra MedFacts Consumer Leaflet (Wolters Kluwer)
- Tocilizumab Professional Patient Advice (Wolters Kluwer)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


